Institutional Ownership 4 D Molecular Therapeutics, Inc. (FDMT)
This table provides information about the institutional ownership of 4 D Molecular Therapeutics, Inc. (FDMT). We have compiled data on the 124 institutions that hold shares in the stock, with a total of 41.2 Million shares, which have been reported (via 13F filing form) to have a value of $287 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,896,897
shares
|
$34.1 Million
0.0% of portfolio
|
Q2 2024
Added 14.29%
|
|
Bvf Inc
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
4,629,289
shares
|
$32.3 Million
0.67% of portfolio
|
Q2 2025
Added 1.49%
|
|
Ra Capital Management, L.P.
Boston, MA |
Aug 14, 2025 Q2 2025 |
4,563,211
shares
|
$31.8 Million
0.37% of portfolio
|
Q4 2024
Reduced 10.49%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
4,159,264
shares
|
$29 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.22%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
2,736,671
shares
|
$19.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.75%
|
|
Novo Holdings
Hellerup, G7 |
Aug 14, 2025 Q2 2025 |
2,000,000
shares
|
$13.9 Million
0.65% of portfolio
|
Q2 2025
Added 2.56%
|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
1,754,410
shares
|
$12.2 Million
0.0% of portfolio
|
Q2 2025
Reduced 7.27%
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Aug 13, 2025 Q2 2025 |
1,667,338
shares
|
$11.6 Million
0.01% of portfolio
|
Q2 2025
Added 33.37%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
1,483,724
shares
|
$10.3 Million
0.0% of portfolio
|
Q2 2025
Reduced 9.2%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
961,962
shares
|
$6.7 Million
0.0% of portfolio
|
Q2 2025
Reduced 6.42%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
924,676
shares
|
$6.44 Million
0.0% of portfolio
|
Q2 2025
Reduced 47.96%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
918,533
shares
|
$6.4 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.64%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
897,070
shares
|
$6.25 Million
0.0% of portfolio
|
Q2 2025
Added 28.46%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
886,705
shares
|
$6.18 Million
0.0% of portfolio
|
Q1 2025
Added 8.13%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
743,400
shares
|
$5.18 Million
0.01% of portfolio
|
Q2 2025
Added 51.59%
|
|
Assenagon Asset Management S.A.
|
Jul 11, 2025 Q2 2025 |
648,825
shares
|
$4.52 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.33%
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
531,163
shares
|
$3.7 Million
0.0% of portfolio
|
Q2 2025
Added 15.11%
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Aug 14, 2025 Q2 2025 |
514,614
shares
|
$3.59 Million
0.04% of portfolio
|
Q2 2025
Reduced 2.4%
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Aug 14, 2025 Q2 2025 |
455,470
shares
|
$3.17 Million
0.0% of portfolio
|
Q2 2025
Added 54.72%
|
|
Acadian Asset Management LLC
Boston, MA |
Aug 07, 2025 Q2 2025 |
330,591
shares
|
$2.3 Million
0.0% of portfolio
|
Q2 2025
Reduced 17.48%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
328,975
shares
|
$2.29 Million
0.0% of portfolio
|
Q2 2025
Reduced 13.64%
|
|
Peapod Lane Capital LLC
Bedford Hills, NY |
Jul 31, 2025 Q2 2025 |
318,537
shares
|
$2.22 Million
1.18% of portfolio
|
Q2 2025
Added 62.64%
|
|
Armistice Capital, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
300,000
shares
|
$2.09 Million
0.02% of portfolio
|
Q4 2024
Reduced 10.71%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
295,041
shares
|
$2.06 Million
0.0% of portfolio
|
Q2 2025
Added 4.34%
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
257,620
shares
|
$1.8 Million
0.0% of portfolio
|
Q2 2025
Added 62.75%
|